Method for treating blepharitis
OwnerMitchell H. Friedlaenderinventor
Life of this patent
Estimating the term…
Abstract
The present invention is related to a method for treating blepharitis, the method comprising administering to an ocular area of a subject in need thereof a composition comprising about 0.001% to about 0.01% (w/v) dexamethasone and an antibiotic, wherein the composition is substantially free of lipids, and wherein the composition is ophthalmically acceptable.
Claims25
A method for treating blepharitis, the method comprising administering to an ocular area of a subject in need thereof a composition comprising about 0.001% to about 0.01% (w/v) dexamethasone and an antibiotic, wherein the composition is substantially free of lipids, and wherein the composition is ophthalmically acceptable.
A composition comprising:
- (a) about 0.0005% to about 0.01% (w/v) dexamethasone;
- (b) about 0.005% to about 0.5% (w/v) gentamicin;
- and
- (c) about 0.1% to about 1.0% (w/v) carboxymethylcellulose,
- wherein the composition is substantially free of lipids.
A composition comprising:
- (a) about 0.005% (w/v) dexamethasone;
- (b) about 0.02% (w/v) gentamicin;
- (c) about 0.625% (w/v) carboxymethylcellulose;
- and
- (d) about 0.015% (w/v) benzalkonium chloride;
- wherein the composition has a pH of about 4.0 to about 7.0, and wherein the composition is substantially free of lipids.
A kit comprising:
- (a) a composition comprising about 0.001% to about 0.01% (w/v) dexamethasone and an antibiotic, wherein the composition is substantially free of lipids, and wherein the composition is ophthalmically acceptable;
- and
- (b) instructions for using the composition of (a) for the treatment of blepharitis.
The kit of claim 25, further comprising a means for administering the composition.
Dependencies are inferred from the claim text.